Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
iXensor CoROCO:6734 +6.44%50 3-Year ROIIC % is 404.40 as of Dec. 2025. GuruFocus rates ROCO:6734 with a GF Score™ of 50/100 and a GF Value™ of NT$5.72 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 795 Medical Devices & Instruments companies, iXensor Co ranks better than 96.1% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
iXensor Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 404.40%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for iXensor Co's 3-Year ROIIC % or its related term are showing as below:
ROCO:6734's 3-Year ROIIC % is ranked better than 96.1% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 1.57
vs ROCO:6734: 404.40
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
iXensor Co 3-Year ROIIC % Related Terms
iXensor Co 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for iXensor Co's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6734 vs ABT, SYK, MDT: 3-Year ROIIC % Comparison
For the Medical Devices subindustry, iXensor Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iXensor Co 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iXensor Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where iXensor Co's 3-Year ROIIC % falls into.
iXensor Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -45.714 (Dec. 2025) - -5.234 (Dec. 2022) )
/
( 40.344 (Dec. 2025) - 50.354 (Dec. 2022) )
=
-40.48
/
-10.01
=
404.40%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
iXensor Co (ROCO:6734) has a 3-Year ROIIC % of 404.40 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on iXensor Co and its competitors. According to the industry distribution chart, iXensor Co ranks #31 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 3.9%.
Is iXensor Co's 3-Year ROIIC % too high?
iXensor Co's current 3-Year ROIIC % is 404.40. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.57. iXensor Co's value of 404.40 is 25658% above this industry median. Based on the distribution chart, iXensor Co ranks #31 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, iXensor Co has a GF Score™ of 50/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does iXensor Co's 3-Year ROIIC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, iXensor Co ranks #31 out of 795 companies for 3-Year ROIIC %. This places iXensor Co in the top 4% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 1.57. iXensor Co's value of 404.40 is 25658% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.57, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iXensor Co's current 3-Year ROIIC % of 404.40 is 25658% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on iXensor Co and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iXensor Co's current 3-Year ROIIC % is 404.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iXensor Co stock overvalued right now?
Based on GuruFocus' analysis, iXensor Co (ROCO:6734) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$5.72, compared to a current price of NT$6.94 — trading 21.3% above its estimated fair value. The current 3-Year ROIIC % is 404.40 and 25658% above the Medical Devices & Instruments industry median of 1.57. iXensor Co's overall GF Score™ is 50/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For iXensor Co (ROCO:6734), the current 3-Year ROIIC % is 404.40 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iXensor Co (ROCO:6734) Overvalued in 2026?
Based on GuruFocus' analysis, iXensor Co stock appears to be overvalued.
The current stock price of NT$6.94 is trading 21.3% above its estimated GF Value™ of NT$5.72.
GuruFocus considers iXensor Co to be Modestly Overvalued.
Key valuation signals for ROCO:6734:
3-Year ROIIC %: 404.40
GF Value™: NT$5.72 vs. price of NT$6.94 (21.3% above fair value)
Industry Position: 25658% above the Medical Devices & Instruments median (#31 of 795)
No single metric tells the full story. See the ROCO:6734 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
iXensor Co Ltd is a Taiwan based company involved in research and development, manufacturing and sales of medical equipment. Its PixoTest technology utilizes the lighting and image sensing module of the smartphone or mobile device to detect the color change reaction on the biochemical test strip. This enables the users to monitor their conditions of diabetes, cardiovascular diseases, women health problems, or infectious diseases.
50GF Score
Get the complete analysis for ROCO:6734
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6734 has been successfully added to your 
